Without exceptions, at this point in time and with the many significant positives in play, each and every GALE Bashing comment is intended and designed to weaken GALE investor resolve. This sort of game is played in perpetuity by those who seek to buy shares (and thus cover their existing short positions) at the lowest prices possible. HOLDING one's LONG position/s precludes and prevents Bashers' successful stock manipulation efforts.
once in a while it's important to let others know the true nature of this 'sara' character....
sara is a pimp anal-list working for an india-based firm. this sara guy is full of hot curry and one who often prefers to cross-dress in hoping to appear as a prospective bride....
Much as I would wish NOT to agree with your comments, Truth is Truth, and from my many years of immersion in the "Market," i must regretfully and sadly agree with almost every element you've presented..
Nothing better than a Fool making a Public Fool of himself..... Sorry, Ryan, but it would have been "Wiser" for you to have informed yourself BEFORE placing uninformed remarks in writing for all to see. Specifically, you fail to acknowledge Ph3 Interim Data reporting, and you also ignore the upcoming announcement of a fully-enrolled Ph3 study. More obscure than these two probabilities (to be announced within the next few months) the possibilities of licensing and/or partnership considerations and you, Ryan, are willing to "guess" as to price and timing???? I agree with HOLDING, but I'd definitely not venture to guess timing associated with "upside." Respectfully, Dan
This is not about "dirty pool," it's simply "the Market." We all know these events are made to happen by individuals and by programs specifically designed to do as we witness. No big deal. As for GALE, I strongly suspect Q-4 results will support the stock's ventures to $5++ Respectfully, Dan
Exit: While you're correct in somewhat minimizing the 176k share number, what's of MAJOR significance is the simple fact that GALE is definitely registering ON THE RADAR SCREENS of ever-increasing numbers of "institutional" interests. Every time another block of 100k+ shares is tucked away, we LONGS benefit. We take away the GALE Players' ability to "play this stock." They (the players) suffer as we Longs enjoy the stock's expanding support base. PLUS, those whose major pursuits are the Shorting of GALE must increasingly cringe as batches of stock are "squirreled away." To hell with the "players." We don't need them - they're nothing more than blood-sucking leaches, roaches, bed-bugs, and weasels. . From what I'm "seeing" happening, we are fast approaching a potentially serious Short Squeeze, the likes of which might result in a one or two day exaggerated surge sending the share price a few points higher than "necessary" and possibly approaching $10 per share. Respectfully, Dan
Read the 34 Billion Dollar Fund article, it's a Must Read! Forget the BS posted by naysayers!!! It's obvious GALE is ripe for the picking, certainly as defined by the actions of increasing numbers of "Funds" and "institutions." This, folks, is where and when the train begins to depart the station. If you've been on the sidelines waiting for others to act, this is either your time to "buy," or just stand back and watch with probable regret. If you've taken the chance of dipping your toes into the GALE pool, consider taking the plunge. If you're vested to your heart's contentment, HOLD on for a highly probable rewarding ride. Those of you who advocate "shorting," good luck and be sure to "cover" before each day's end of trading. There will always be those inevitable moguls on the slope, the ups and downs. HOWEVER, consider judging your GALE investment actions Not on a daily or on a weekly basis. Consider assessing your GALE objectives Monthly or Quarterly! With more than 30 years extensive "Market" experience and with an 18 months vested interest in GALE, this monthly/quarterly re-evaluation of my GALE actions have served me (and many other "longs") Very, Very well. Respectfully, Dan
Yes, some dips here & there, but otherwise steady and UP over time. Q-4 Abstral data will increase confidence as sales numbers begin to point towards $40Million+ annual net sales. NeuVax Phase III enrollments are fast approaching the 700 (target) objective. NeuVax Ph3 Interim data (approx 6 mos away) will very likely send GALE above $10. Growing confidence + just a bit of patience and you've got nothing less than a Solid Winner! Respectfully, Dan
With respect for your loss, and with intimate knowledge of a loved-one's battle with BC, I'd have to guess that almost every woman who is made aware of how NeuVax might provide added hope and possibly longer survival chances - almost every scenario of this kind would opt to at least TRY the NeuVax treatments. Knowing NeuVax will Absolutely NOT cause harm, and will be less consequential than the chemo battles - almost every woman not ready to give up the fight would volunteer to participate in the NeuVax Ph3 Trials!!! Respectfully, Dan
Believe me, my wife would most likely be alive today had she been afforded the NeuVax advantages! By the same token, NeuVax is not a "cure" and, therefore, allows for continued assessments over time. In other words, NeuVax might minimize aspects of cancer-related expenses and treatments, but does not seek to cut the medical professionals out of the loop. The "medical community" is often deep-set in its ways, reluctant to change, ill-informed of new technologies, and topped by arrogance, thus demanding of a sadly sticken patient that SHE (and her support) be made responsible for research and discovery of agents and opportunities such as NeuVax. All the while, the average MD oncologist is reaping in hundreds of thousands of dollars annually while performing at a "mediocre" level of performance and competencies!
"Blame" for the fact that thousands of women immersed in their battle to survive haven't been made aware of NeuVax - have not been Informed of Ph3 Trials - were never given the NeuVax option and the very promising "advantages" of reduced Recurrence rates..... All via a relatively simple vaccine treatment protocol. Keep in mind: NO HARM DONE by NeuVax! Damaging are the stubborn docs who are either too full of themselves or simply lacking in knowledge - either way the patients lose out, including an earlier onset of Recurrence, more suffering, and sooner loss of life!
Fact: NeuVax causes NO harm! (As easily and as well tolerated as a flu shot.) SHAME on each and every Oncologist whose patient/s over the course of the past two years would have “qualified” to participate in NeuVax Phase III trials but whose docs never presented the NeuVax option. SHAME on the doctors who prevented patients from participating in the NeuVax trials! SHAME on those oncology specialists who have been neglectful and/or who are conflicted by self interests that supersede the best interests of their patients. Yes, SHAME on the hundreds of self-righteous clinicians whose attitudes reflect a mindset of “too busy or too smart” to absorb new knowledge! Thousands of breast cancer patients have received “traditional therapy” but without the added potential benefits of a harmless vaccine! Shame on the majority of the medical community who otherwise purports to “care” but who have failed thousands of women in Fighting the BEST of a good fight: "No Holds Barred." Remember: NeuVax causes NO HARM! Although the benefits of NeuVax await Phase III results (or might prove less than statistically effective), increasing compelling evidence logically suggests:
"USE it!" No harm done, yet with a great potential to accomplish Good.” What a Shame that Phase III NeuVax clinicals patient enrollment was not completed Months ago!!! Respectfully, Dan
Almost all of us who are here LONG are proof positive our Patient, LONG positions have yielded excellent results! Those who Shorted own mostly LOSSES and Tears. This is a fact!!! You're an idiot and a Fool if you short this stock at this time. Why so? Because the multitudes of variables surrounding and affecting this stock would put any Short at a much higher Risk of generating losses than would a conservative Buy and HOLD! Remember: NeuVax is highly likely to achieve results the likes of which have not been accomplished within the World of Oncology in more than 20 years. If you're unwilling or unable to educate yourself to this reality, then by all means, you're the perfect GALE shorting candidate. Respectfully, Dan
What excellent and appropriate commentaries!!! Also keep in mind the ongoing FBP (Folate Binding Protein) testing, while reliant upon a polypeptide different from NeuVax, is nevertheless an immunotherapy technology not vastly apart from the NeuVax efforts. As to the off-label extrapolations of NeuVax: Virtually Limitless! A vast frontier of explorations. BEST of all, NeuVax DOES NO HARM - - - as you've stated, NO negative side effects (clearly what one would expect considering NeuVax is an otherwise innocuous protein) . Huge Potential, a Grand Horizon. The dawning of an extraordinary immunotherapy technological era right before our eyes!!!! Very Exciting!!!
Kenny: please, please do as you suggest (not really). You're fundamentally lacking in data, in facts, in understanding, and in your basic knowledge of the possible ramifications surrounding NeuVax. You truly and honestly don't belong here. Ignorance is NOT bliss here! This GALE "play" is not well suited for intellectually challenged "generalists" who view the Pharma world through one lens, one perspective, and with minimum knowledge. Don't misunderstand my comments: FDA NeuVax approval is absolutely not guaranteed. However, important data have clearly defined NeuVax as a prime contender in generating the most significant Oncological breakthrough of the past two decades. KNOW Herceptin, then multiply that reality by at least a factor of 2 and possibly more. Kenny, believe me when as I attempt to convey to you the following: "You're dangerous to yourself because you're unaware of what you don't know." Respectfully, Dan
May I suggest you remain an idiot in trying to apply logic where and when none exists AND in the course of events that are totally unpredictable (yes, even to a great thinker such as you). You "believe" yourself to possess such insights as knowing (in advance) the day Full Enrollment (Ph3) is announced? How about a prospective partnership announcement? How about possibly increased Institutional buying? How about the timing of some Short Covering? Do you really enjoy putting yourself in this position of making absurd suggestions only to have fools such as me tear apart at your seams?
For those keeping score, it's December & we're increasingly close to a fully-enrolled NeuVax Phase III trial. Although my expectations would have this matter announced during Q-1 of 14, the possibilities of this 700-patient study being fully enrolled (sooner rather than later) remain viable. Respectfully, Dan
Some of your "opinions," while making for a bit of entertainment, seem lacking in "substance" (as well as in science). Care to grant us an insight into your scientific background? BTW, long before your Grace manifested this GALE board, there had been active discussions regarding mgmt.'s stock ownership. We've been aware (for more than 18 months) of the upcoming "issuances" of stock (to key mgmt). While you've been busy focusing upon the 0-cost basis of these reserved shares, those of us with (perhaps) a deeper sense of Company history will be judging Company management's future stock activities NOT by the shares they own (nor the cost-basis of those shares), but more importantly, by the shares any one party of the mgmt group might seek to SELL! Finally, considering your espoused superior intellect, please do elaborate as to why, as you've stated that "in your opinion," the NeuVax vaccine is destined to fail?? (Please support your conclusions within the framework of logical, documented, scientific data/studies.) Respectfully, Dan